Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

An investigation of seven patients analyzed use of a pressure device worn overnight to supplement other therapy for auricular keloids (scar tissue buildup of the ear), was reported in an article published Online First today by Archives of Facial Plastic Surgery, one of the JAMA/Archives journals…

 

In 1997, the actress and singer Julie Andrews lost her singing voice following surgery to remove noncancerous lesions from her vocal cords. She came to Steven Zeitels, a professor of laryngeal surgery at Harvard Medical School, for help. Zeitels was already starting to develop a new type of material that could be implanted into scarred vocal cords to restore their normal function…

 

MuteButton, an Irish company which has developed a novel medical device to successfully treat people suffering from permanent tinnitus, has secured a €200,000 ($285,000) investment from Enterprise Ireland. Permanent tinnitus is estimated to affect over 20,000 people in Ireland alone and over 40 million people globally…

 

Masimo (NASDAQ: MASI) announced FDA 510(k) Clearance, CE Mark, and limited market release of the industry’s first single-patient-use ear sensor. Compared to digit sensors, the Masimo E1™ enables faster detection of oxygen saturation changes during low perfusion due to a variety of clinical factors, including sedative or medication-induced vasoconstriction…

 

Light, or photodynamic, therapy can help preserve the voice and vocal cord function for patients with early stage laryngeal (voice box) cancer, according to a study from Henry Ford Hospital in Detroit…

 

From a baby’s first blurted “bowl!’” for the word “ball” to the whispered goodbye of a beloved elder, the capacity for complex vocalizations is one of humankind’s most remarkable attributes — and perhaps one we take for granted most of our lives. Not so for people who are afflicted with paralysis to their vocal folds and who suffer the social stigma of affected speech…

 

Dr. Rohan Walvekar, Assistant Professor of Otolaryngology Head and Neck Surgery, Director of Clinical Research and the Salivary Endoscopy Service at LSU Health Sciences Center New Orleans, has reported the first use of a surgical robot guided by a miniature salivary endoscope to remove a 20mm salivary stone and repair the salivary duct of a 31-year-old patient…

 

The 2010 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, convened September 26-29, 2010, in Boston, MA…

 

The 2010 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, is being held September 26-29, 2010, in Boston, MA…

 

This July, House Ear Institute (HEI) celebrates the 30th Anniversary of the first pediatric cochlear implant. HEI received FDA approval for a clinical trial in July 1980 to implant three patients under the age of 18 with the single-channel cochlear implant. The single-channel device had been developed at HEI by William House, M.D., in the 1960s and successfully implanted in adults…




February 2012
Mon Tue Wed Thu Fri Sat Sun
« Jan    
 12345
6789101112
13141516171819
20212223242526
272829